)
)
ADMA Biologics Investor Relations Material
Latest events
Q3 2024
ADMA Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from ADMA Biologics Inc
Access all reports
ADMA Biologics Inc. is a biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived products. The company focuses on producing and marketing therapies for patients with immune deficiencies and other immune-compromised conditions. ADMA Biologics' product portfolio includes immunoglobulin therapies that help prevent infections in individuals with weakened immune systems. In addition to developing its own products, the company operates plasma collection centers to support its manufacturing needs and ensure a stable supply of raw materials. The company is headquartered in Ramsey, New Jersey, and its shares are listed on the Nasdaq Stock Market.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
ADMA
Country
🇺🇸 United States